Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The epiretinal membrane (ERM) and internal limiting membrane (ILM) are structural components of the vitreoretinal interface in the human eye. The ILM is a true basement membrane, primarily composed of collagen type IV, laminin, and fibronectin, which serves as the boundary between the retina and the vitreous body [1]. The ERM is a pathological, fibrocellular tissue that proliferates on the inner surface of the ILM, often resulting from posterior vitreous detachment or inflammatory processes [2]. These structures are not traditional molecular targets like receptors or enzymes; instead, they are physical targets for surgical removal, known as membrane peeling, to treat conditions such as macular puckers and macular holes [3]. Pharmacological intervention is limited, though the proteolytic enzyme ocriplasmin is used to dissolve protein links at this interface to treat vitreomacular traction [4]. Surgical visualization of these thin, transparent membranes is often enhanced using vital dyes like Brilliant Blue G or Indocyanine Green, which selectively bind to the membrane components [5]. Understanding the mechanical and biochemical properties of these membranes is crucial for improving outcomes in vitreoretinal surgery and developing non-invasive therapies for tractional maculopathies.
Proteolytic degradation of laminin and fibronectin at the vitreoretinal interface (Ocriplasmin); Selective staining and visualization for surgical removal (Vital dyes)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epiretinal membrane and internal limiting membrane (ERM/ILM).